Want to see TSE:CRRX full AI Analyst Report?
Total Valuation
CareRx has a market cap or net worth of C$220.63M. The enterprise value is C$264.57M.
Market CapC$220.63M
Enterprise ValueC$264.57M
Share Statistics
CareRx has 63,453,266 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,453,266
Owned by Insiders36.64%
Owned by Institutions―
Financial Efficiency
CareRx’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 6.01%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)6.01%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee260.18K
Profits Per Employee18.36K
Employee Count1,423
Asset Turnover1.46
Inventory Turnover15.82
Valuation Ratios
The current PE Ratio of CareRx is 8.1. CareRx’s PEG ratio is -0.01.
PE Ratio8.1
PS Ratio0.65
PB Ratio2.19
Price to Fair Value2.19
Price to FCF10.92
Price to Operating Cash Flow7.78
PEG Ratio-0.01
Income Statement
In the last 12 months, CareRx had revenue of 370.24M and earned 26.13M in profits. Earnings per share was 0.42.
Revenue370.24M
Gross Profit92.63M
Operating Income11.88M
Pretax Income3.35M
Net Income26.13M
EBITDA30.22M
Earnings Per Share (EPS)0.42
Cash Flow
In the last 12 months, operating cash flow was 28.14M and capital expenditures -4.61M, giving a free cash flow of 23.52M billion.
Operating Cash Flow28.14M
Free Cash Flow23.52M
Free Cash Flow per Share0.37
Dividends & Yields
CareRx pays an annual dividend of C$0.02, resulting in a dividend yield of 1.03%
Dividend Per ShareC$0.02
Dividend Yield1.03%
Payout Ratio-400.00%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change23.58%
50-Day Moving Average3.41
200-Day Moving Average3.58
Relative Strength Index (RSI)62.44
Average Volume (3m)71.09K
Important Dates
CareRx upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
CareRx as a current ratio of 1.06, with Debt / Equity ratio of 70.78%
Current Ratio1.06
Quick Ratio0.78
Debt to Market Cap0.17
Net Debt to EBITDA2.10
Interest Coverage Ratio1.74
Taxes
In the past 12 months, CareRx has paid -22.77M in taxes.
Income Tax-22.77M
Effective Tax Rate-6.79
Enterprise Valuation
CareRx EV to EBITDA ratio is 10.03, with an EV/FCF ratio of 13.81.
EV to Sales0.82
EV to EBITDA10.03
EV to Free Cash Flow13.81
EV to Operating Cash Flow11.01
Balance Sheet
CareRx has C$15.32M in cash and marketable securities with C$78.13M in debt, giving a net cash position of -C$62.81M billion.
Cash & Marketable SecuritiesC$15.32M
Total DebtC$78.13M
Net Cash-C$62.81M
Net Cash Per Share-C$0.99
Tangible Book Value Per ShareC$0.17
Margins
Gross margin is 26.47%, with operating margin of 3.21%, and net profit margin of 7.06%.
Gross Margin26.47%
Operating Margin3.21%
Pretax Margin0.91%
Net Profit Margin7.06%
EBITDA Margin8.16%
EBIT Margin3.21%
Analyst Forecast
The average price target for CareRx is C$5.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetC$5.25
Price Target Upside38.52% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast2.20%
EPS Growth Forecast―